This purpose of this study is to investigate the effect of the self-regulation mode of continuous blood glucose monitoring on blood glucose indicators, self-efficacy, health-promoting behaviors, and medication compliance in patients with Type 2 diabetes. A prospective, randomized, double-blind experimental study is designed with 60 diabetic patients randomly assigned to the experimental group receiving continuous blood glucose monitoring and self-regulation mode of health education and the control group receiving self-monitoring of blood glucose and routine health education. Data will be collected three times, including blood glucose indicators and scales of self-efficacy, health promotion behaviors, and medication compliance.
Age range
20 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Fasting blood glucose
Timeframe: Pre-test(baseline)
Fasting blood glucose
Timeframe: 7 days during intervention
Fasting blood glucose
Timeframe: 3 months after intervention
24-hr blood glucose
Timeframe: 7 days during intervention
HbA1C
Timeframe: Pre-test(baseline)
HbA1C
Timeframe: 3 months after intervention
Diabetes self-efficacy scale
Timeframe: Pre-test(baseline)
Diabetes self-efficacy scale
Timeframe: 8 days after intervention
Diabetes self-efficacy scale
Timeframe: 3 months after intervention
Diabetes health promoting behavior scale
Timeframe: Pre-test(baseline)
Diabetes health promoting behavior scale
Timeframe: 8 days after intervention
Diabetes health promoting behavior scale
Timeframe: 3 months after intervention
Medication compliance
Timeframe: Pre-test(baseline)
Medication compliance
Timeframe: 8 days after intervention
Medication compliance
Timeframe: 3 months after intervention